Exousia Bio Company Description

Exousia Bio, Inc., a biotechnology company, designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells.

The company’s platform enables the custom production of exosomes with enhanced genetic functionality that can selectively target specific cells to address diseases.

The company was formerly known as LAMY and changed its name to Exousia Bio, Inc. in January 2026. The company was incorporated in 2022 and is based in Saint Petersburg, Florida.

Exousia Bio, Inc.

Country	United States
Founded	2022
Industry	Education & Training Services
Sector	Consumer Staples
Employees	2
CEO	Matthew Dwyer

Contact Details

Address: 7901 4th Street N Saint Petersburg, Florida 33702 United States
Phone	509-605-6533
Website	exousiabio.com

Stock Details

Ticker Symbol	LMMY
Exchange	OTCMKTS
Stock Type	Common Stock
Fiscal Year	June - May
Reporting Currency	USD
ISIN Number	US50172J1051
SIC Code	2836

Key Executives

Name	Position
Matthew Dwyer	Chief Executive Officer
Matthew Dwyer	Chief Financial Officer